Objective: To evaluate the maternal-neonatal outcome in magnesium (Mg)-intoxicated women with preeclampsia with severe features (PESF) treated with magnesium sulfate (MgSO₄). Methods: A total of 19 Mg intoxicated PESF women (cases) were compared with 166 PESF women without signs of intoxication (controls). Results: Mg serum levels of cases was higher compared to control group (12.36 ± 3.54 mg/dl versus 2.69 ± 0.83 mg/dl). 3 women died and 3 had major maternal morbidity in cases group compared with zero in the control group (P = 0.009). Mg intoxication was also significantly associated with perinatal deaths and low Apgar scores at 1 and 5 minutes. Conclusion: Mg intoxication is associated with a increased risk of maternal and perinatal morta...
Objective: To study efficacy of Magnesium Sulphate in reducing maternal morbidity and mortality in p...
Abstract Background and Objective The pharmacokinetic basis of magnesium sulphate (MgSO4) dosing reg...
Objective: To assess the effectiveness of magnesium sulfate as a neuroprotective agent in early pret...
Background: Preeclampsia is a significant public health problem in developed and developing countrie...
Tocolytic use of magnesium sulphate is associated with excess neonatal mortality and has been propos...
Tocolytic use of magnesium sulphate is associated with excess neonatal mortality and has been propos...
Tocolytic use of magnesium sulphate is associated with excess neonatal mortality and has been propos...
Tocolytic use of magnesium sulphate is associated with excess neonatal mortality and has been propos...
Background: Preeclampsia is the second cause of maternal mortality in the United States and accounts...
Objectives: To evaluate the level of serum magnesium in pregnant women with severe preeclampsia and ...
Objective: To assess whether long-term use of magnesium sulphate prolongs pregnancy in patients with...
Background Pre-eclampsia and the subsequent eclampsia account for a common cause of maternal mortali...
Introduction: Magnesium sulfate (MgSC4) is the agent most commonly used for treatment of eclampsia a...
Background: The present study was planned to study the role of Mg in preeclampsia and its correlatio...
Objective: The definitive treatment of preeclampsia until the fetus and placenta are delivered with ...
Objective: To study efficacy of Magnesium Sulphate in reducing maternal morbidity and mortality in p...
Abstract Background and Objective The pharmacokinetic basis of magnesium sulphate (MgSO4) dosing reg...
Objective: To assess the effectiveness of magnesium sulfate as a neuroprotective agent in early pret...
Background: Preeclampsia is a significant public health problem in developed and developing countrie...
Tocolytic use of magnesium sulphate is associated with excess neonatal mortality and has been propos...
Tocolytic use of magnesium sulphate is associated with excess neonatal mortality and has been propos...
Tocolytic use of magnesium sulphate is associated with excess neonatal mortality and has been propos...
Tocolytic use of magnesium sulphate is associated with excess neonatal mortality and has been propos...
Background: Preeclampsia is the second cause of maternal mortality in the United States and accounts...
Objectives: To evaluate the level of serum magnesium in pregnant women with severe preeclampsia and ...
Objective: To assess whether long-term use of magnesium sulphate prolongs pregnancy in patients with...
Background Pre-eclampsia and the subsequent eclampsia account for a common cause of maternal mortali...
Introduction: Magnesium sulfate (MgSC4) is the agent most commonly used for treatment of eclampsia a...
Background: The present study was planned to study the role of Mg in preeclampsia and its correlatio...
Objective: The definitive treatment of preeclampsia until the fetus and placenta are delivered with ...
Objective: To study efficacy of Magnesium Sulphate in reducing maternal morbidity and mortality in p...
Abstract Background and Objective The pharmacokinetic basis of magnesium sulphate (MgSO4) dosing reg...
Objective: To assess the effectiveness of magnesium sulfate as a neuroprotective agent in early pret...